MASSDEVICE ON CALL — Republican presidential hopeful Rick Santorum told CNN that he supports privatizing Medicare and wants to eliminate the Centers for Medicare & Medicaid Services.
Santorum said that private-sector competition should completely replace the government’s role in health care.
"You want the private sector out there competing, driving down costs, improving efficiency," Santorum told the news agency. "You want to get rid of this — of CMS, where government basically micromanages all healthcare through Medicare and Medicaid."
Sign up to get our free newsletters delivered straight to your inbox
There would be little difference between current co-pays and supplemental coverage for seniors and a privatized insurance plan, according to Santorum.
Health care policy experts disagree with the republican candidate, estimating that the rising cost of health care would force seniors to spend more of their own money, according to TheHill.com
Ernst & Young gets “all clear” from Olympus audits review panel
The panel reviewing the Japanese arm of auditing firm Ernst & Young audits of Olympus Corp. has yet to find any problems, according to Reuters. Ernst & Young questioned the accuracy of separate auditors in catching Olympus’ $1.7 billion accounting scam. Read more
Excess heart monitors waste money, raise false alarms
Wide spread use of heart monitors in hospitals wastes money and can cause doctors to miss important patient cues, according to Boston.com. A NIH-funded study found that 26% of patients being monitored for abnormal heart rhythms didn’t qualify for monitoring. Read more
Concussion lawsuits could mean big trouble for NFL
The rising number of lawsuits filed against the National Football League for its handling of concussions could put dozens of players before juries, according to the New York Times. Read more
Medtronic, Alnylam RNAi preclinical data looks promising
The med-tech titan’s RNAi drug-device combo with Alnylam Pharmaceuticals wowed researchers with its preclinical data, according to Fierce news. In its preclinical trials, the drug-device combination treats Huntington’s disease in the brain. Read more
